Monte Rosa Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Monte Rosa Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2022 to 2023.
  • Monte Rosa Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $71K, a 58.2% decline year-over-year.
  • Monte Rosa Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $384K, a 6.67% increase year-over-year.
  • Monte Rosa Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was $338K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
* An asterisk sign (*) next to the value indicates that the value is likely invalid.